To Study the effect of Udumber Twak Ghanvati in Asrugdara.

Single arm clinical study to evaluate efficacy of Udumbar Twak Ghanvati in Asrugdara.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/10/028229

Enrollment

Registered

2020-10-05

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Udumbar Twak Ghanvati: 60 patients will be selected and treated with Udumbar twak Ghanvati and dose will be 500mg once in a day with dugdhasharkara yukta annapan.Duration of study will

Eligibility

Inclusion criteria

Inclusion criteria: 1) Written informed consent & voluntarily willing patients will be taken for this study. 2)Patients complaining of excessive or prolonged menstrual bleeding or inter menstrual bleeding for 2 consecutive cycles. 3)Hb % - Above 8 gm%.

Exclusion criteria

Exclusion criteria: 1)Patients with IUCD and on OC pills or on hormonal treatment. 2)PCOD,STD,Blood coagulopathy. 3) Immunoâ?? compromised patients. 4)Associated with other systemic diseases like HTN, TB, DM. 5)Bleeding from polyps,fibroid, Ca, erosions, trauma etc. 6)On medication like Aspirin, clopitab.

Design outcomes

Primary

Measure	Time frame
1)Asrugdara is the common problem noticed in majority of patients in our clinical practice. 2) To evatuate and establish safer,cost-effective Ayurvedic remedy for Asrugdara. Timepoint: Patient should be assessed for 3 consecutive cycles for 1st 5 days of menstrual flow	—

Secondary

Measure	Time frame
1)To improve physiological condition 2)To give her a safe cheap side effect free ayurvedic managementTimepoint: 90 days	—

Countries

India

Contacts

Public ContactDr Sayali Gourishankar Belage

Dr D Y Patil ayurvedic college pimpri pune

hridaynath.lad@gmail.com9822964454

Outcome results